Charles River Lb
Price
Price
CHART BY
Frequently asked questions
What is Charles River Lb's market capitalization?
What is Charles River Lb's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Charles River Lb?
What are the analyst ratings and target price for Charles River Lb's stock?
What is Charles River Lb's revenue over the trailing twelve months?
What is the EBITDA for Charles River Lb?
What is the free cash flow of Charles River Lb?
How many employees does Charles River Lb have, and what sector and industry does it belong to?
What is the free float of Charles River Lb's shares?
Financials
- Market Cap
- $8.37B
- EPS (TTM)
- $8.098
- Free Float
- 50.59M
- P/E ratio (TTM)
- 20.21
- Revenue (TTM)
- $4.06B
- EBITDA (TTM)
- $951.40M
- Free Cashflow (TTM)
- $560.48M
Pricing
- 1D span
- $159.88$165.62
- 52W span
- $160.00$274.69
Analyst Ratings
The price target is $192.25 and the stock is covered by 21 analysts.
Buy
5
Hold
13
Sell
3
Information
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
- Employees
- 21,800
- Industries
- Miscellaneous Commercial Services
- Sector
- Health Care
Identifier
- ISIN
- US1598641074
- Primary Ticker
- CRL